Dr. Flaxenburg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1914 Lelaray Street
Colorado Springs, CO 80909Phone+1 719-632-7641Fax+1 719-632-2925
Education & Training
- Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2002 - 2006
- Brigham and Women's HospitalResidency, Internal Medicine, 1999 - 2002
- Yale School of MedicineClass of 1999
Certifications & Licensure
- CO State Medical License 2006 - 2025
- MA State Medical License 2001 - 2007
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 43 citationsGlomerular Disease in Temporal Association with SARS-CoV-2 Vaccination: A Series of 29 Cases.Tiffany N Caza, Clarissa A Cassol, Nidia Messias, Andrew Hannoudi, Randy S Haun
Kidney360. 2021-11-25 - 12 citationsTRAF6 inhibits proangiogenic signals in endothelial cells and regulates the expression of vascular endothelial growth factor.Sarah Bruneau, Dipak Datta, Jesse A. Flaxenburg, Soumitro Pal, David M. Briscoe
Biochemical and Biophysical Research Communications. 2012-03-02 - 129 citationsRas-induced Modulation of CXCL10 and Its Receptor Splice Variant CXCR3-B in MDA-MB-435 and MCF-7 Cells: Relevance for the Development of Human Breast CancerDipak Datta, Jesse A. Flaxenburg, Sreenivas Laxmanan, Christopher Geehan, Martin Grimm
Cancer Research. 2006-10-01
Press Mentions
- Colorado Springs Top Doctors 2018October 9th, 2018
- Top Docs 2016October 2nd, 2016
Grant Support
- Vascular Endothelial Growth Factor In AlloimmunityNational Heart, Lung, And Blood Institute2003–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: